2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Primary Mediastinal Large B-cell Lymphoma: new trials by email Literature Review of Primary Mediastinal Large B-cell Lymphoma trials Research Report on Primary Mediastinal Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy Efineptakin alfa, Tisagenlecleucel, Axicabtagene ciloleucel - Refractory Diffuse Large B-cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | Completed | NeoImmuneTech | 17 | 2021-07-29 | 2026-08-10 |
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL Tazemetostat, Prednisolone - B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1) | Phase 1 / Phase 2 | Completed | Epizyme, Inc. | 400 | 2013-06-13 | 2024-03-26 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphoma, B-Cell (1)
Methylprednisolone (1) · Prednisolone (1) · axicabtagene ciloleucel (1) · efineptakin alfa (1) · prednisolone acetate (1) · prednisolone phosphate (1) · tazemetostat (1) · tisagenlecleucel (1)
Epizyme, Inc. (1) · NeoImmuneTech (1)
United States (2) · Australia (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Taiwan (1) · Ukraine (1) · United Kingdom (1)